Successful Bilateral Lung Transplantation for Lymphangiomatosis

Overview

Journal Am J Transplant

Publisher Elsevier

Specialty General Surgery

Date 2008 Aug 2

PMID 18671675

Citations 9

Authors

C V Kinnier

J P C Eu

R D Davis

D N Howell

J Sheets

S M Palmer

Affiliations

Soon will be listed here.

Abstract

Lymphangiomatosis is a rare disease of lymphatic proliferation for which no adequate treatment is known. We report the first successful case of bilateral lung transplantation for the treatment of end-stage pulmonary lymphangiomatosis. A successful outcome was achieved with continued survival beyond 4 years posttransplant and stable lung function. The primary obstacles to significant gains in pulmonary function were thoracic, skeletal and abdominal lymphangiomatosis, which led to pulmonary restriction. Our report demonstrates that pulmonary lymphangiomatosis should be included among those diseases for which lung transplantation is considered potentially beneficial treatment but also emphasizes the importance of screening patients carefully for chest wall and abdominal lymphangiomas that may impede recovery.

Citing Articles

Pulmonary lymphangiomatosis: insights into an ultra-rare disease.

Polke M, Polke N, Piel S, Brunnemer E, Walscher J, Buschulte K Respir Res. 2024; 25(1):416.

PMID: 39593123 PMC: 11600747. DOI: 10.1186/s12931-024-03040-5.

Effective Initial Treatment of Diffuse Pulmonary Lymphangiomatosis with Sirolimus and Propranolol: A Case Report.

Dimiene I, Bieksiene K, Zaveckiene J, Andrulis M, Optazaite D, Vaguliene N Medicina (Kaunas). 2021; 57(12).

PMID: 34946253 PMC: 8706407. DOI: 10.3390/medicina57121308.

Japanese clinical practice guidelines for vascular anomalies 2017.

Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K Jpn J Radiol. 2020; 38(4):287-342.

PMID: 32207066 PMC: 7150662. DOI: 10.1007/s11604-019-00885-5.

Japanese clinical practice guidelines for vascular anomalies 2017.

Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K Pediatr Int. 2020; 62(3):257-304.

PMID: 32202048 PMC: 7232443. DOI: 10.1111/ped.14077.

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K J Dermatol. 2020; 47(5):e138-e183.

PMID: 32200557 PMC: 7317503. DOI: 10.1111/1346-8138.15189.

References

Hamada K, Ishii Y, Nakaya M, Sawabata N, Fukuda K, Suzuki H . Solitary lymphangioma of the lung. Histopathology. 1995; 27(5):482-3. DOI: 10.1111/j.1365-2559.1995.tb00316.x. View

Taveira-DaSilva A, Steagall W, Moss J . Lymphangioleiomyomatosis. Cancer Control. 2006; 13(4):276-85. DOI: 10.1177/107327480601300405. View

Laverdiere C, David M, Dubois J, Russo P, Hershon L, Lapierre J . Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol. 2000; 29(4):321-4. DOI: 10.1002/(sici)1099-0496(200004)29:4<321::aid-ppul13>3.0.co;2-c. View

Ra S, Bradley R, Fishbein M, Busuttil R, Lu D, Lassman C . Recurrent hepatic lymphangiomatosis after orthotopic liver transplantation. Liver Transpl. 2007; 13(11):1593-7. DOI: 10.1002/lt.21306. View

Ramani P, Shah A . Lymphangiomatosis. Histologic and immunohistochemical analysis of four cases. Am J Surg Pathol. 1993; 17(4):329-35. View

Rostom A . Treatment of thoracic lymphangiomatosis. Arch Dis Child. 2000; 83(2):138-9. PMC: 1718438. DOI: 10.1136/adc.83.2.138. View

Reinhardt M, Nelson S, Sencer S, Bostrom B, Kurachek S, NESBIT M . Treatment of childhood lymphangiomas with interferon-alpha. J Pediatr Hematol Oncol. 1997; 19(3):232-6. DOI: 10.1097/00043426-199705000-00010. View

BROWSE N, ALLEN D, Wilson N . Management of chylothorax. Br J Surg. 1998; 84(12):1711-6. View

Zisis C, Spiliotopoulos K, Patronis M, Filippakis G, Stratakos G, Tzelepis G . Diffuse lymphangiomatosis: are there any clinical or therapeutic standards?. J Thorac Cardiovasc Surg. 2007; 133(6):1664-5. DOI: 10.1016/j.jtcvs.2007.02.005. View

10.

. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-1980. N Engl J Med. 1980; 303(5):270-6. DOI: 10.1056/NEJM198007313030508. View

11.

Molitch H, Unger E, Witte C, Vansonnenberg E . Percutaneous sclerotherapy of lymphangiomas. Radiology. 1995; 194(2):343-7. DOI: 10.1148/radiology.194.2.7529933. View

12.

Shah L . Lung transplantation in sarcoidosis. Semin Respir Crit Care Med. 2007; 28(1):134-40. DOI: 10.1055/s-2007-970339. View

13.

Bhatti M, Ferrante J, Gielchinsky I, Norman J . Pleuropulmonary and skeletal lymphangiomatosis with chylothorax and chylopericardium. Ann Thorac Surg. 1985; 40(4):398-401. DOI: 10.1016/s0003-4975(10)60078-1. View

14.

Ozeki M, Funato M, Kanda K, Ito M, Teramoto T, Kaneko H . Clinical improvement of diffuse lymphangiomatosis with pegylated interferon alfa-2b therapy: case report and review of the literature. Pediatr Hematol Oncol. 2007; 24(7):513-24. DOI: 10.1080/08880010701533603. View

15.

Pechet T, Meyers B, Guthrie T, Battafarano R, Trulock E, Cooper J . Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant. 2004; 23(3):301-8. DOI: 10.1016/S1053-2498(03)00195-5. View

16.

Faul J, Berry G, Colby T, Ruoss S, Walter M, Rosen G . Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000; 161(3 Pt 1):1037-46. DOI: 10.1164/ajrccm.161.3.9904056. View

17.

Kandil A, Rostom A, Mourad W, Khafaga Y, Gershuny A . Successful control of extensive thoracic lymphangiomatosis by irradiation. Clin Oncol (R Coll Radiol). 1997; 9(6):407-11. DOI: 10.1016/s0936-6555(97)80140-9. View

18.

Tazelaar H, Kerr D, Yousem S, Saldana M, Langston C, Colby T . Diffuse pulmonary lymphangiomatosis. Hum Pathol. 1993; 24(12):1313-22. DOI: 10.1016/0046-8177(93)90265-i. View